Back to results
US 2020/0390765 A1Published application
Methods for modulating splicing
AssigneeSkyhawk Therapeutics, Inc.
InventorsMichael Luzzio, Kathleen McCarthy, Botao Liu
Life of this patent
Estimating the term…
Abstract
Described herein are methods of use of small molecule splicing modulator compounds that modulate splicing of mRNA, such as pre-mRNA, encoded by genes, and methods of treating diseases and conditions associated with gene expression or activity of proteins encoded by genes.
Claims20
A method of decreasing expression of a target protein, comprising contacting a small molecule splicing modulator (SMSM) to a pre-mRNA encoded by a gene of the target protein or a cell comprising the pre-mRNA,
- wherein the SMSM binds to the pre-mRNA to generate a spliced product of the pre-mRNA;
- wherein the spliced product of the pre-mRNA comprises
- i) a poison exon,
- ii) a frame-shift and a premature termination codon downstream of the frame-shift, or
- iii) a poison exon and an intron immediately downstream of the poison exon;
- wherein the spliced product of the pre-mRNA undergoes nonsense-mediated mRNA decay (NMD) and/or nuclear retention;
- and
- wherein expression of the target protein encoded by the spliced product is decreased.
5 more elements
(canceled)
Dependencies are inferred from the claim text.